SAN DIEGO — Sequenom, Inc., a life sciences company providing innovative genetic analysis solutions, today announced that the company has been upgraded to the NASDAQ Global Select Market, a segment of the NASDAQ Global Market with the highest initial listing standards of any exchange in the world. Sequenom will continue to trade under the ticker […]
SANTA BARBARA, Calif.– SpectraFluidics Inc., a company that specializes in developing and manufacturing vapor trace chemical detection technology, was recently awarded a $1.3 million contract from the U.S. Department of Homeland Security, Transportation Security Administration (DHS/TSA). The scope of the award is to develop and validate a vapor detection system that quickly and efficiently detects […]
Stuttgart – Carl Zeiss ended fiscal year 2010/11 (reporting date: 30 September 2011) with a clear increase in revenue and earnings over the prior year: with a total of EUR 4.237b, revenue topped the four billion euro mark for the very first time (prior year: EUR 2.981b). Earnings (EbIT) totaled EUR 607m (prior year: EUR […]
WASHINGTON — Ahead of an institutional investor and analyst meeting to be held in New York, Danaher Corporation (NYSE: DHR) reaffirmed the Company’s fourth quarter 2011 adjusted diluted earnings per share guidance of $0.75 – $0.80. The fourth quarter guidance includes $0.74 – $0.79 of earnings per share from continuing operations and $0.01 of earnings […]
Pleasanton, California: IntegenX Inc., the leading developer of rapid human DNA identification technology and DNA sequencing library preparation systems, has secured $40 Million in Series C funding to accelerate development of the company’s product pipeline and the commercialization of its RapidHIT™ 200 Human Identification System into domestic and international markets. Industry observers expect this product […]
CYTOO, a company that specializes in micropattern-enhanced cell-based assays, has teamed up with Cenix BioScience, a pioneer in developing industrial high-content screening applications of RNAi, and three European academic partners to challenge the current limits of high throughput (HT) RNAi screening in cultured cells. The SME-driven project, coordinated by CYTOO, aims to combine HT applications […]
BILLERICA, Mass., Millipore Corporation, the Life Science business of Merck KGaA of Germany, that operates as EMD Millipore in the U.S. and Canada, today announced that all its remaining outstanding 3.75% Convertible Senior Notes Due 2026 (the “Notes”) were redeemed on December 1, 2011, at one hundred percent (100%) of the outstanding principle amount of […]
FRANKLIN LAKES, N.J. — The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 45 cents per common share, an increase of 4 cents per share, or about 10 percent, from the previous quarter. The dividend will be payable on December 30, 2011 to holders of record […]
Grenoble, France – CYTOO SA, a company that specializes in cell-based assays, announced today the closing of a series C funding round of USD 10M (EUR 7M). New investors, Sham and Entrepreneurs Fund (EF), led the round. Existing investors AURIGA Partners and Jacques Lewiner, co-founder and president of the supervisory board at CYTOO, also participated. […]
NEW YORK – Fitch Ratings has affirmed Bio-Rad Laboratories Inc.’s (Bio-Rad) ratings, including the ‘BBB-‘ Issuer Default Rating (IDR). The ratings apply to approximately $738 million in debt outstanding at Sept. 30, 2011. The Rating Outlook is Stable. A full ratings list follows at the end of this press release. Bio-Rad’s ‘BBB-‘ IDR reflects the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
